Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (391-400 of 427) with videos related to

Pageof 43
Sort By:
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Cancer Research|November 10, 2012
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerNicholas I Fleming, Robert N Jorissen, Dmitri Mouradov, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2011
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancerJeanne Tie, Lara Lipton, Jayesh Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerFiona L Day, Robert N Jorissen, Lara Lipton, et al.
International Journal of Cancer|September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studiesJeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
The Journal of Molecular Diagnostics : JMD|November 17, 2022
Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair StatusRomy Walker, Peter Georgeson, Khalid Mahmood, et al.
The New England Journal of Medicine|June 3, 2022
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon CancerJeanne Tie, Joshua D Cohen, Kamel Lahouel, et al.
Pageof 43

Showing results (391-400 of 427) with videos related to

Sort By:
Pageof 43
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Cancer Research|November 10, 2012
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerNicholas I Fleming, Robert N Jorissen, Dmitri Mouradov, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2011
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancerJeanne Tie, Lara Lipton, Jayesh Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerFiona L Day, Robert N Jorissen, Lara Lipton, et al.
International Journal of Cancer|September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studiesJeanne Tie, Joshua D Cohen, Serigne N Lo, et al.
The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.
The Journal of Molecular Diagnostics : JMD|November 17, 2022
Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair StatusRomy Walker, Peter Georgeson, Khalid Mahmood, et al.
The New England Journal of Medicine|June 3, 2022
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon CancerJeanne Tie, Joshua D Cohen, Kamel Lahouel, et al.
Pageof 43